Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases

Immunosuppressive Medications and COVID-19 Outcomes in Patients with Noninfectious Uveitis in the Era of COVID-19 Vaccinations

“…Other studies assessing steroid doses and COVID-19 outcomes in those with autoimmune conditions have found that steroid doses ≥ 7.5 mg/day and ≥ 10 mg/day were associated with a higher risk of hospitalization, which is consistent with our findings. 13 , 14 , 15 , 16 …”

Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases

“…The American College of Rheumatology (ACR) and the European League Against Rheumatism strongly recommended the vaccination for SARS-CoV-2 of rheumatic disease (RD) patients from the beginning of the pandemic, and guidance on COVID-19 vaccination has occasionally been updated [ 1 , 2 ]. The vaccination was reported to be useful for RD patients [3] . Vaccination began in 2020 in Europe and the United States, but was delayed until February 2021 in Japan.…”